![]() | |
![]() 3-Iodo-L-tyrosine | |
Names | |
---|---|
IUPAC name
(2S)-2-Amino-3-(4-hydroxy-3-iodophenyl)propanoic acid | |
Other names
Monoiodotyrosine; MIT[1] | |
Identifiers | |
| |
3D model (JSmol) |
|
ChEMBL | |
ChemSpider |
|
DrugBank |
|
ECHA InfoCard | 100.000.677 ![]() |
MeSH | Monoiodotyrosine |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C9H10INO3 | |
Molar mass | 307.087 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
3-Iodotyrosine is an intermediate in the synthesis of thyroid hormones which is derived from iodinationoftyrosine at the meta-position of the benzene ring. One unit can combine with diiodotyrosine to form triiodothyronine, as occurs in the colloid of the thyroid follicle. Two units can combine to form 3,3'-diiodothyronine.
3-Iodotyrosine is a reversible inhibitor of the enzyme tyrosine hydroxylase.[2]
3-Iodotyrosine, a pathway inhibitor in the synthesis of the neurotransmitter dopamine, was used to determine the effects of decreased dopamine levels in social spacing of Drosophila melanogaster. 3-4 day old flies that were fed 3-iodotyrosine for 24 hours were shown to have altered dopamine levels.[3]
| |
---|---|
Tyrosine / iodotyrosine |
|
Thyronine / iodothyronine |
|
Thyronamine / iodothyronamine |
|
Iodothyroacetate / iodothyroacetic acid |
|